Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Return on Assets (2021 - 2025)

Historic Return on Assets for Tango Therapeutics (TNGX) over the last 5 years, with Q3 2025 value amounting to 0.45%.

  • Tango Therapeutics' Return on Assets fell 1100.0% to 0.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45%, marking a year-over-year decrease of 1100.0%. This contributed to the annual value of 0.36% for FY2024, which is 1200.0% down from last year.
  • Latest data reveals that Tango Therapeutics reported Return on Assets of 0.45% as of Q3 2025, which was down 1100.0% from 0.57% recorded in Q2 2025.
  • Over the past 5 years, Tango Therapeutics' Return on Assets peaked at 0.1% during Q3 2021, and registered a low of 0.57% during Q2 2025.
  • In the last 5 years, Tango Therapeutics' Return on Assets had a median value of 0.26% in 2021 and averaged 0.28%.
  • As far as peak fluctuations go, Tango Therapeutics' Return on Assets surged by 600bps in 2022, and later crashed by -2700bps in 2025.
  • Tango Therapeutics' Return on Assets (Quarter) stood at 0.11% in 2021, then plummeted by -113bps to 0.24% in 2022, then decreased by -2bps to 0.24% in 2023, then crashed by -59bps to 0.39% in 2024, then decreased by -15bps to 0.45% in 2025.
  • Its Return on Assets stands at 0.45% for Q3 2025, versus 0.57% for Q2 2025 and 0.45% for Q1 2025.